Chevy Chase Trust Holdings Inc. increased its stake in shares of Aetna Inc. (NYSE:AET) by 1.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 294,265 shares of the company’s stock after purchasing an additional 3,144 shares during the period. Chevy Chase Trust Holdings Inc. owned 0.09% of Aetna worth $46,791,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of the stock. Capital World Investors raised its holdings in Aetna by 8.9% in the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock valued at $3,153,358,000 after acquiring an additional 1,688,767 shares during the last quarter. FMR LLC raised its holdings in Aetna by 73.8% in the 2nd quarter. FMR LLC now owns 13,736,800 shares of the company’s stock valued at $2,085,659,000 after acquiring an additional 5,833,567 shares during the last quarter. Janus Henderson Group PLC raised its holdings in Aetna by 9,446.2% in the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock valued at $657,255,000 after acquiring an additional 4,283,553 shares during the last quarter. UBS Asset Management Americas Inc. raised its holdings in Aetna by 7.5% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 2,553,496 shares of the company’s stock valued at $387,697,000 after acquiring an additional 177,364 shares during the last quarter. Finally, LSV Asset Management raised its holdings in Aetna by 8.7% in the 2nd quarter. LSV Asset Management now owns 2,467,782 shares of the company’s stock valued at $374,683,000 after acquiring an additional 198,214 shares during the last quarter. Hedge funds and other institutional investors own 88.03% of the company’s stock.
Shares of Aetna Inc. (NYSE AET) opened at $178.83 on Friday. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52. Aetna Inc. has a 12 month low of $116.04 and a 12 month high of $192.37. The stock has a market cap of $58,320.00, a price-to-earnings ratio of 17.52, a PEG ratio of 1.63 and a beta of 0.61.
Aetna (NYSE:AET) last announced its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, topping analysts’ consensus estimates of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The firm had revenue of $14.99 billion during the quarter, compared to analysts’ expectations of $15.12 billion. During the same period in the prior year, the company earned $2.07 EPS. The firm’s revenue was down 5.0% on a year-over-year basis. sell-side analysts predict that Aetna Inc. will post 9.78 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Thursday, January 11th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a yield of 1.12%. Aetna’s dividend payout ratio (DPR) is 36.97%.
In related news, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the sale, the president now directly owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by corporate insiders.
Several brokerages have weighed in on AET. Argus downgraded Aetna from a “buy” rating to a “hold” rating and set a $185.00 price target for the company. in a report on Wednesday. Zacks Investment Research downgraded Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Credit Suisse Group reiterated a “neutral” rating and issued a $195.00 price target (up from $174.00) on shares of Aetna in a report on Wednesday. Wells Fargo & Company reiterated an “outperform” rating and issued a $208.00 price target (up from $200.00) on shares of Aetna in a report on Monday. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $175.00 price objective on shares of Aetna in a research note on Monday, October 23rd. Twelve analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $175.19.
TRADEMARK VIOLATION NOTICE: This piece was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.dispatchtribunal.com/2017/12/08/chevy-chase-trust-holdings-inc-raises-position-in-aetna-inc-aet.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.